Synthesis of two metabolites of 2,4-diamino-5(3,4,5-trimethoxybenzyl)-pyrimidines (Trimethoprim)

The synthesis of two metabolites M₃ and M₄ of 2,4-diamino-5-(3, 4, 5-trimethoxybenzyl)-pyrimidine (trimethoprim, 1 ) is reported. M₃ (trimethoprim 1-oxide) as well as the isomeric 3-oxide were prepared by oxidation of 1 with m-chloroperbenzoic acid. The structure of M₃ was finally established by x-ra analysis [4]. The metabolite M₄ [2, 4-diamino-5-(3-hydroxy-4, 5-dimethoxy-benzyl)-pyrimidine] was prepared by condensation of 3-benzyloxy-4, 5-dimethoxybenzaldehyde ( 2 ) with 3-methoxypropionitrile ( 3 ) and guanidine followed by hydrogenolysis of the intermediate 3-benzyloxy compound 4 .     

New ferrocenyl heterometallic complexes of 2,7-diethynylfluoren-9-one

A new series of rigid-rod alkynylferrocenyl precursors with central fluoren-9-one bridge, 2-bromo-7-(2-ferrocenylethynyl)fluoren-9-one (1b), 2-trimethylsilylethynyl-7-(2-ferrocenylethynyl)fluoren-9-one (2) and 2-ethynyl-7-(2-ferrocenylethynyl)fluoren-9-one (3), have been prepared in moderate to good yields. The ferrocenylacetylene complex 3 can provide a direct access to novel heterometallic complexes, trans-[(η⁵-C₅H₅)Fe(η⁵-C₅H₄)CCRCCPt(PEt₃)₂Ph] (4), trans-[(η⁵-C₅H₅)Fe(η⁵-C₅H₄)CCRCCPt(PBu₃)₂CCRCC(η⁵-C₅H₄)Fe(η⁵-C₅H₅)] (5), [(η⁵-C₅H₅)Fe(η⁵-C₅H₄)CCRCCAu(PPh₃)] (6) and [(η⁵-C₅H₅)Fe(η⁵-C₅H₄)CCRCCHgMe] (7) (R=fluoren-9-one-2,7-diyl), following the CuI-catalyzed dehydrohalogenation reactions with the appropriate metal chloride compounds. All the new complexes have been characterized by FTIR, ¹H-NMR and UV–vis spectroscopies and fast atom bombardment mass spectrometry. The solid state molecular structures of 3, 5, 6 and 7 have been established by X-ray crystallography. The redox chemistry of these mixed-metal species has been investigated by cyclic voltammetry and oxidation of the ferrocenyl moiety is facilitated by the presence of the heavy metal centre and increased conjugation in the chain through the ethynyl and fluorenone linkage units.     

The synthesis of some 4-nitroisothiazoles as potential antifungal agents

5-Chloro-3-methyl-4-nitroisothiazole (III) was prepared by nitration of 5-chloro-3-methyliso-thiazole. Compound III was found to exhibit significant antifungal activity in vitro against a wide spectrum of fungi. The synthesis of 3-methyl-4-nitro-5-nitroamino, 5-carboxamido, 5-N,N-dimethylamino and 5-β-hydroxyethylaminoisothiazole are here reported. The synthesis of 3-methyl-4-nitroso-5-ethylthioisothiazole (IX) is reported via an unusual reaction of 5-bromo-3-methyl-4-nitroisothiazole (I) and sodium ethyl mercaptide. 5-Bromo-4-nitroisothiazole was prepared by nitration of 5-bromoisothiazole. The nitro group was shown to be essential for antifungal activity.     

Synthesis of 2-[3′-(trifluoromethyl)anilino] -5-hydroxynicotinic acid

2-[3′-(Trifluoromethyl)anilino]-5-hydroxynicotinic acid (2) was synthesized by two routes: a) by direct hydroxylation of 2-[3′-(trifluoromethyl)anilino]nicotinie acid (1) ; and b) by the following sequence starting from 2-chloro-3-methyl-5-nitropyridine (3) via 5-amino-2-chloro-3-methylpyridine (4) , 2-ehloro-5-hydroxy-3-methylpyridine (6) , 5-acetoxy-2-chloro-3-methylpyridine (7) , 5-acetoxy-2-chloronicotinie acid (8) , and 2-chloro-5-hydroxynicotinic acid (9). The correlation of 2 with one of the metabolites of 1 has been accomplished, and the identities of both compounds have been proven.     

Evaluation of membranes of copolypeptide of γ-benzyl -glutamate and -glutamic acid for the permeability of anticancer drugs

The membranes of poly(γ-benzyl -glutamate-co- -glutamic acid) [P(BLG-LGA)] were prepared by saponification of poly(γ-benzyl -glutamate) (PBLG) membranes. The permeation of two anticancer drugs, 5-fluoro-uracil (5-fu) and 2-hydroxyethyl-oxy-methyl-5-fluoro-uracil (2-HEOM-5-Fu), through these membranes was studied. The results showed a sharp increase in permeability of the copolymer membranes compared to the PBLG membranes.     

Features of the reaction of 3(5)-methyl-5(3)-trifluoromethylpyrazole with chloroform. Synthesis and structure of fluorinated analogs of tris(pyrazol-1-yl)methane

Reaction of 3(5)-methyl-5(3)-trifluoromethylpyrazole (I) with chloroform leads to a complex mixture of compounds. The main components are {bis[(5-methyl-3-trifluoromethyl)pyrazol-1-yl](3-methyl-5-trifluoromethyl)pyrazol-1-yl}methane, bis{[(3-methyl-5-trifluoromethyl)pyrazol-1-yl](5-methyl-3-trifluoromethyl)-pyrazol-1-yl}methane, and tris[(3-methyl-5-trifluoro-methyl)pyrazol-1-yl]methane. The structure of isomeric substances was proved by XRD method.     

Fragmentation reactions of the enolate ions of 2-pentanone

The reaction of [OH]^? with 2-pentanone produces two enolate ions, [CH₃CH₂CH₂COCH₂]^? and [CH₃COCHCH₂CH₃]^?, by proton abstraction from C(1) and C(3), respectively. Using deuterium isotopic labelling the fragmentation reactions of each enolate have been delineated for collisional activation at both high (8 keV) and low (5–100 eV) collisional energies. The primary enolate ion fragments mainly by elimination of ethene. Two mechanisms operate: elimination of C(4) and C(5) with hydrogen migration from C(5), and elimination of C(3) and C(4) with migration of the C(5) methyl group. Minor fragmentation of the primary enolate also occurs by elimination of propane and elimination of C₂H₅; the latter reaction involves specifically the terminal ethyl group. The secondary enolate ion fragments mainly by loss of H₂ and by elimination of CH₄; for the latter reaction four different pathways are operative. Minor elimination of ethene also is observed involving migration of a C(5) hydrogen to C(3) and elimination of C(4) and C(5) as ethene.     

三(三甲硅基)环戊二烯基三羰基钼负离子的反应性

三(三甲硅基)环戊二烯基三羰基钼负离子锂盐[{η^5-(Me~3Si)~3C~5H~2}Mo(CO)~3]^-Li^+(1), 分别与MeI、phCH~2Cl及ClCH~2COOC~2H~5反应生成相应的烃基化钼衍生物[{η^5-(Me~3Si)~3C~5H~2}Mo(CO)~3R,] (R=-CH~3, 2; -CH~2ph, 3;-CH~2COOC~2H~5, 4)。1与PCl~3反应除得到预期的钼氯化物[{η^5-(Me~3Si)~3C~5H~2}Mo(CO)~3Cl](5)外, 主要得到钼磷氯化物[{η^5-(Me~3Si)~3C~5H~2}Mo(CO)~3PCl~2] 6; 1与碘反应得到钼碘化物[{η^5-(Me~3Si)~3C~5H~2}Mo(CO)~3I] 7; 1与HOAc作用后分别和CCl~4、NBS室温反应, 仅分离到脱去一个Me~3Si的钼卤化物[{η^5-(Me~3Si)~2C~5H~2}Mo(CO)~3X], (X:Cl, 8; Br, 9)。     

Antiinflammatory,analgesic and kinase inhibition activities of some acridine derivatives

9-Chloro-2,4-(un)substituted acridines (1) on condensation with sulpha- diazine, sulphathiazole, and sulphaacetamide gave condensation products 3a-h. 3-Aryl-4-phenyl-2-imino-4-thiazolines (4) on condensation with 9-chloro-2,4-(un)substituted acridines (1) gave condensation products 5a–5o. Both 3a–3h and 5a–5o were purified by crystallization or by chromatography. Structures assigned to 3a–3h and 5a–5o are supported by correct spectral data. Antiinflammatory and analgesic activity screening of 3a, 3e, 3f and 5a–5c, 5e, 5g, 5i, 5m, 5n were carried out using carrageenin induced paw oedema and phenyl quinone writhing assay. Some of the compounds exhibited interesting antiinflammatory or analgesic activities.     

Reaction of cis-3-bromo-1,2-dibenzoylpropene with amines

The reaction of cis-3-bromo-1,2-dibenzoylpropene (1) with amines proceeds by means of a substitution-rearrangement attack to give the 2-(α-aminoacetophenonyl)acrylophenones ( 2 ). Like similar structures, 2 undergoes further substitution-rearrangement by amines to give 3-benzoyl-5-phenylpyrroles ( 5 ) and an enaminoketone, α-acetophenonyl-β-aminoacrylophenone ( 3 ). Competitive with substitution-rearrangement, amine addition to 2 followed by loss of hydrogen and then water leads to formation of the 3-benzoyl-4-amino-5-phenylpyrroles ( 4 ). The enaminoketones ( 3 ) by contrast with 2 are quite stable. Structure 2 when in polar solvents or in the presence of amines undergoes substitution-rearrangement to give 3 , which can be induced to give the pyrroles ( 5 ) when exposed to acid conditions. When neat or in solvents of low polarity, 2 undergoes intermolecular substitution-rearrangement-dehydration to give 5 almost exclusively. A novel addition reaction of 3-benzoyl-5-phenylfuran involving attack by isopropyl- or cyclohexylamine provides a quantitative method of synthesizing the appropriate N-substituted examples of 3 and an efficient method of deriving the corresponding pyrroles ( 5 ).     

The lively chemistry of the di-μ-methylene-bis(pentamethylcyclopentadienyl-rhodium) complexes, analogues of surface reactions in heterogeneous catalysis

The chemistry of the di-μ-methylene-bis(pentamethylcyclopentadienyl-rhodium) complexes is reviewed. The complex [{(η⁵-C₅Me₅)RhCl₂}₂] (1a) reacted with MeLi to give, after oxidative work-up, blood-red cis-[{(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(Me)₂], 2. This has the two rhodiums in the +4 oxidation state (d⁵), and linked by a metal-metal bond (2.620 Å). Trans-2 was formed on isomerisation of cis-2 in the presence of Lewis acids, or by direct reaction of 1a with Al₂Me₆, followed by dehydrogenation with acetone. The Rh-methyls in [{(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(Me)₂] were readily replaced under acidic conditions (HX) to give [{(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(X)₂] (X = Cl, Br or I); these latter complexes reacted with a variety of RMgX to give [{(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(R)₂] (R = alkyl, Ph, vinyl, etc.). Trans-2 also reacted with HBF₄ in the presence of L to give first [{(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(Me)(L)]⁺ and then [{(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(L)₂]²⁺ (L = MeCN, CO, etc.). The {(η⁵-C₅Me₅)Rh(μ-CH₂)}₂ core is rather kinetically inert and also forms a variety of complexes with oxy-ligands, both cis-, e.g. [{(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(μ-OAc)]⁺ and trans-, such as [(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(H₂O)₂]²⁺. The complexes [{(η⁵-C₅Me₅)Rh(μ-CH₂)}₂(R)L]⁺ (R = Me or aryl) in the presence of CO, or [{(η⁵-C₄Me₅)Rh(μ-CH₂)}₂(R)₂] (R = Me, Ph or CO₂Me) in the presence of mild oxidants, readily yield the C---C---C coupled products RCH=CH₂. The mechanisms of these couplings have been elucidated by detailed labelling studies: they are more complex than expected, but allow direct analogies to be drawn to C---C couplints that occur during Fischer-Tropsch reactions on rhodium surfaces.     

2-氨基-3-羟基环戊烯-1-腈衍生物的合成和晶体结构

用低价钛试剂(TiCl~4-Zn)与α,α-(4-氯苯基)(二氰甲基)甲基苯基酮反应合成了非对映消旋体(3R,5S;3S,5R)和(3R,5R;3S,5S)2-氨基-3-羟基-3-苯基-5-对氯苯基环戊烯-1-腈。并用X射线衍射分析确定了这两个非对映异构体的构型。     

新型S(N)-β-D-葡萄糖苷-4-N-(取代邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑的合成及生物活性

在KOH/acetone体系中,4-N-(取代邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑-3-硫酮(3a～3d)与溴-α-D-四乙酰葡萄糖发生Kenigs-Knorr反应,合成了8个未见报道的S(N)-β-D-乙酰葡萄糖苷,其结构经1H NMR、13C NMR、红外光谱及元素分析等确定.目标化合物的生物活性测试结果表明,它们对金黄色葡萄球菌、白色念珠菌和大肠杆菌均显示了较好的抑菌活性,其效果接近或优于对照药物三氯生和氟康唑的抑菌效能.其中,化合物2-N-(2’,3’,4’,6’-O-四乙酰基-β-D-吡喃葡萄糖基)-4-N-(3,5-二溴邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑-3-硫酮(4d)及3-S-(2’,3’,4’,6’-O-四乙酰基-β-D-吡喃葡萄糖硫基)-4-N-(3,5-二溴邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑(5d)具有较强的抑菌活性.     

A New Convergent Synthesis of Thiamine Hydrochloride

Thiamine hydrochloride ( 1a ; 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methylthia-zolium chloride hydrochloride; vitamin B¹) has been synthesized in excellent yield by condensation of 3-mercapto-4-oxopentyl acetate (5a) with 3, 4-dihydro-7-methylpyrimido[4, 5-d]pyrimidine (4) in formic acid. The two intermediates 5a and 4 are prepared from 3-chloro-4-oxopentyl acetate (3) and 4-amino-2-methyl-5-(aminomethyl)-pyrimidine (Grewe diamine; 2a ), respectively.     

Synthesis of 2-(2′,3′-dihydroxypropyl)-5-amino-2H-1,2,4-thiadiazol-3-one and 3-(2′,3′-dihydroxypropyl)-5-amino-3H-1,3,4-thiadiazol-2-one

The synthesis of two new acyclic nucleoside analogs, 2-(2′,3′-dihydroxypropyl)-5-amino-2H-1,2,4-thiadiazol-3-one (1) and 3-(2′,3′-dihydroxypropyl)-5-amino-3H-1,3,4-thiadiazol-2-one (2), is reported. The first compound, 1, was obtained by reaction of 3-chloro-1,2-propanediol with the sodium salt of 5-amino-2H-1,2,4-thiadiazol-3-one (3) in anhydrous dimethylformamide. Similarly, 5-amino-3H-1,3,4-thiadiazol-2-one (4) reacted with 3-chloro-1,2-propanediol to give 2. The thiadiazole 4 was prepared by condensation-cyclization of hydrazothiodicarbonamide (9).     

Synthesis of some substituted pyridylsydnones

Synthesis of the I-oxide ( 2 ) of the photochromic N-(3-pyridyl) sydnone ( 1 ), of N-(5-bromo-3-pyridyl) sydnone ( 3 ), and the I-oxide ( 4 ) of 3 were undertaken in order to study the effect on photochromism exerted by substituents on the pyridine ring. Compounds 2 and 3 were prepared via the corresponding aminopyridines and N-pyridylglycines by the general procedure used earlier to prepare 1 . The required amines, 3-aminopyridine I-oxide and 3-amino-5-bromopyridine, were obtained by Hofmann rearrangement of the corresponding amides. An excellent preparation of 5-bromonicotinamide was developed involving bromination in thionyl chloride followed by reaction of the bromoacid chloride with ammonia in chloroform. Proof of structure for 2 and 3 was accomplished by acid hydrolysis to the corresponding hydrazines, which were isolated, respectively, as acetophenone 3-pyridylhydrazone I-oxide and as 5-bromo-3-pyridylhydrazine hydrochloride. These products were identical with samples prepared by reduction of the respective diazotized amines. Sydnone 4 eluded preparation by this general procedure. 3-Amino-5-bromopyridine I-oxide was prepared conveniently from 5-bromonicotinamide but attempts to prepare the corresponding glycine by catalytic hydrogenation of a mixture of the amine and butyl glyoxylate afforded, in acid solution, N-(3-pyridyl)glycine and, in neutral or alkaline solution, the I-oxide of N-(3-pyridyl)glycine. Both products resulted from the reductive cleavage of the bromine atom. Neither 2 nor 3 was photochromic.     

Synthesis of certain 1,2,4-triazole nucleoside derivatives

The syntheses of 3-amino-4-methyl-1-(β-D-ribofuranosyl)-1,2,4-triazolin-5-one ( 8a ) and its 2′-deoxy analog 8b as well as 5-amino-2-methyl-1-(β-D-ribofuranosyl)-1,2,4-triazolin-3-one ( 12 ) have been accomplished. Compounds 8a and 8b were synthesized via glycosylation of 3-bromo-5-nitro-1,2,4-triazole which was followed by replacement in three steps of the 3-bromo function to yield 3-nitro-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1,2,4-triazolin-5-one ( 4a ) and its 2′-deoxy analog 4b . Compounds 4a and 4b were methylated at N², hydrogenated and deblocked to give 3-amino-4-methyl-1-(β-D-ribofuranosyl)-1,2,4-triazolin-5-one ( 8a ) and the 2′-deoxy analog 8b . Compound 12 was synthesized by glycosylation of 3-amino-1-methyl-1,2,4-triazolin-5(2H)-one ( 10 ). The structures of 8b and 12 were confirmed by single crystal X-ray diffraction analysis.     

Hydrogen bonds in the crystal packings of mesalazine and mesalazine hydrochloride

The crystal structures of pharmaceutical product mesalazine (marketed also under different proprietary names as Salofalk, Asacol, Asacolitin, and Claversal) and its hydrochloride are reported. In the crystal mesalazine is in zwitterion form as 5-ammoniosalicylate (1) whereas mesalazine hydrochloride crystallizes in an ionized form as 5-ammoniosalicylium chloride (2). Compound 1 (C₇H₇O₃N) crystallizes in the monoclinic space group P2₁/n with a = 3.769(1) Å, b = 7.353(2) Å, c = 23.475(5) Å, β = 94.38(2)°, V = 648.7(8) ų, Z = 4, D_c = 1.568 g cm⁻³ and μ(MoK) = 1.2 cm⁻¹. Compound 2 (C₇H₈O₃NCl) crystallizes in the triclinic space group P with a = 4.4839(2) Å, b = 5.7936(2) Å, c = 15.6819(5) Å, = 81.329(3)°, β = 88.026(3)°, γ = 79.317(4)°, V = 395.74(3) ų, Z = 2, D_c = 1.591 g cm⁻³ and μ(CuK) = 40.8 cm⁻¹. The crystal structures were solved by direct methods and refined to R = 0.041 for 1 and 0.028 for 2, using 607 and 1374 observed reflections, respectively. The configuration of both molecules, with the ortho hydroxyl to a carboxyl group, favours the intramolecular hydrogen bonds. Very complex systems of intermolecular hydrogen bonds were observed in both crystal packings. They are discussed in terms of graph-set notation. The mesalazine crystal structure is characterized by two-dimensional network of hydrogen bonds in the ab plane. The crystal structure pattern of mesalazine hydrochloride is a three-dimensional network significantly supported by N⁺---HCl⁻ interactions.     

Synthesis of s-3-indolemethyl derivatives of 5′-deoxy-5′-thioadenosine

The S-3-(1-methylindole)methyl and S-3-(1,2-dimethylindole)methyl derivatives of 5′-deoxy-5′-thioadenosine have been prepared by reaction of the appropriate 3-indolemethylthioacetate with 5′-deoxy-5′-chloro-adenosine in basic media. 5′-Deoxy-5′-(3-indolemethylthio)adenosines unsubstituted at the indolic nitrogen, cannot be prepared via this route due to facile conversion of the precursor 3-indolemethylthiol derivative to the corresponding 3,3′-diindolemethyl sulfide.     

Microbiological transformation of bicyclic monoterpenes by Absidia orchidis (Vuill.) Hagem. 2. Hydroxylation of fenchone and isofenchone. 18. Section on reactions with microorganisms

(+)-Fenchone ( 3a ) was transformed to 6-exo-hydroxy-fenchone (6β-hydroxy-1, 3, 3-trimethyl-nor-bornan-2-one) ( 1a ) and to 5-exo-hydroxy-fenchone 5β-hydroxy-1, 3, 3-trimethyl-nor-bornan-2-one ( 4a ) by the mycelium of Absidia orchidis (Vuill.) Hagem. The structure of the two products was proven by a detailed analysis of the NMR. spectra of the corresponding acetyl derivatives 2a and 5a respectively, and by CrO₃-oxidation. 1a yielded the β-diketone 6a , and 4a the diketone 8a. Whereas 8a was stable to alkali 6a was cleaved to the cyclopentane carboxylic acids 7 and 9 . — Incubation of (—)-fenchone ( 3b ) yielded the enantiomeric hydroxylation products 1b and 4b in the same ratio. - (—)-Isofenchone ( 11a ) was transformed by Absidia orchidis into the two epimers 6-endo-hydroxy-isofenchone (6β-hydroxy-1, 5, 5-trimethyl-nor-bornan-2-one) ( 12a ) and 6-exo-hydroxy-isofenchone (6β-hydroxy-1, 5, 5-trimethyl-nor-bornan-2-one) ( 10a. ) CrO₃-oxidation of both 10a and 12a gave the same β-diketone 6a. - (+)-Isofenchone gave the corresponding enantiomeric hydroxy derivatives 10b and 12b on incubation with Absidia orchidis.